Cytomegalovirus Biology Viewed Through a Cell Death Suppression Lens

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2025 Jan 8

PMID 39772130

Authors

Edward S Mocarski

Affiliations

Soon will be listed here.

Abstract

Cytomegaloviruses, species-specific members of the betaherpesviruses, encode an impressive array of immune evasion strategies committed to the manipulation of the host immune system enabling these viruses to remain for life in a stand-off with host innate and adaptive immune mechanisms. Even though they are species-restricted, cytomegaloviruses are distributed across a wide range of different mammalian species in which they cause systemic infection involving many different cell types. Regulated, or programmed cell death has a recognized potential to eliminate infected cells prior to completion of viral replication and release of progeny. Cell death also naturally terminates replication during the final stages of replication. Over the past two decades, the host defense potential of known programmed cell death pathways (apoptosis, necroptosis, and pyroptosis), as well as a novel mitochondrial serine protease pathway have been defined through studies of cytomegalovirus-encoded cell death suppressors. Such virus-encoded inhibitors prevent virus-induced, cytokine-induced, and stress-induced death of infected cells while also moderating inflammation. By evading cell death and consequent inflammation as well as innate and adaptive immune clearance, cytomegaloviruses represent successful pathogens that become a critical disease threat when the host immune system is compromised. This review will discuss cell death programs acquired for mammalian host defense against cytomegaloviruses and enumerate the range of modulatory strategies this type of virus employs to balance host defense in favor of lifelong persistence.

References

Chaudhry M, Casalegno-Garduno R, Sitnik K, Kasmapour B, Pulm A, Brizic I . Cytomegalovirus inhibition of extrinsic apoptosis determines fitness and resistance to cytotoxic CD8 T cells. Proc Natl Acad Sci U S A. 2020; 117(23):12961-12968. PMC: 7293702. DOI: 10.1073/pnas.1914667117. View

Kaiser W, Upton J, Mocarski E . Viral modulation of programmed necrosis. Curr Opin Virol. 2013; 3(3):296-306. PMC: 3821070. DOI: 10.1016/j.coviro.2013.05.019. View

Muscolino E, Schmitz R, Loroch S, Caragliano E, Schneider C, Rizzato M . Herpesviruses induce aggregation and selective autophagy of host signalling proteins NEMO and RIPK1 as an immune-evasion mechanism. Nat Microbiol. 2019; 5(2):331-342. DOI: 10.1038/s41564-019-0624-1. View

Tummers B, Green D . The evolution of regulated cell death pathways in animals and their evasion by pathogens. Physiol Rev. 2021; 102(1):411-454. PMC: 8676434. DOI: 10.1152/physrev.00002.2021. View

Hahn G, Rose D, Wagner M, Rhiel S, McVoy M . Cloning of the genomes of human cytomegalovirus strains Toledo, TownevarRIT3, and Towne long as BACs and site-directed mutagenesis using a PCR-based technique. Virology. 2003; 307(1):164-77. DOI: 10.1016/s0042-6822(02)00061-2. View

Goldmacher V, Bartle L, Skaletskaya A, Dionne C, Kedersha N, Vater C . A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc Natl Acad Sci U S A. 1999; 96(22):12536-41. PMC: 22976. DOI: 10.1073/pnas.96.22.12536. View

Feng Y, Daley-Bauer L, Roback L, Potempa M, Lanier L, Mocarski E . Caspase-8 restricts natural killer cell accumulation during MCMV Infection. Med Microbiol Immunol. 2019; 208(3-4):543-554. PMC: 6635065. DOI: 10.1007/s00430-019-00617-6. View

Upton J, Kaiser W, Mocarski E . Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe. 2010; 7(4):302-313. PMC: 4279434. DOI: 10.1016/j.chom.2010.03.006. View

Geballe A, Spaete R, Mocarski E . A cis-acting element within the 5' leader of a cytomegalovirus beta transcript determines kinetic class. Cell. 1986; 46(6):865-72. DOI: 10.1016/0092-8674(86)90068-1. View

10.

Heineman T, Schleiss M, Bernstein D, Spaete R, Yan L, Duke G . A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines. J Infect Dis. 2006; 193(10):1350-60. DOI: 10.1086/503365. View

11.

Guo H, Omoto S, Harris P, Finger J, Bertin J, Gough P . Herpes simplex virus suppresses necroptosis in human cells. Cell Host Microbe. 2015; 17(2):243-51. PMC: 4382104. DOI: 10.1016/j.chom.2015.01.003. View

12.

Cookson B, Brennan M . Pro-inflammatory programmed cell death. Trends Microbiol. 2001; 9(3):113-4. DOI: 10.1016/s0966-842x(00)01936-3. View

13.

Chaudhuri A, St Jeor S, Maciejewski J . Apoptosis induced by human cytomegalovirus infection can be enhanced by cytokines to limit the spread of virus. Exp Hematol. 1999; 27(7):1194-203. DOI: 10.1016/s0301-472x(99)00044-2. View

14.

Fliss P, Pechenick Jowers T, Brinkmann M, Holstermann B, Mack C, Dickinson P . Viral mediated redirection of NEMO/IKKγ to autophagosomes curtails the inflammatory cascade. PLoS Pathog. 2012; 8(2):e1002517. PMC: 3271075. DOI: 10.1371/journal.ppat.1002517. View

15.

Feng Y, Daley-Bauer L, Roback L, Guo H, Koehler H, Potempa M . Caspase-8 restricts antiviral CD8 T cell hyperaccumulation. Proc Natl Acad Sci U S A. 2019; 116(30):15170-15177. PMC: 6660791. DOI: 10.1073/pnas.1904319116. View

16.

Frank D, Vince J . Pyroptosis versus necroptosis: similarities, differences, and crosstalk. Cell Death Differ. 2018; 26(1):99-114. PMC: 6294779. DOI: 10.1038/s41418-018-0212-6. View

17.

Broz P, Pelegrin P, Shao F . The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol. 2019; 20(3):143-157. DOI: 10.1038/s41577-019-0228-2. View

18.

Strasser A, Vaux D . Viewing BCL2 and cell death control from an evolutionary perspective. Cell Death Differ. 2017; 25(1):13-20. PMC: 5729521. DOI: 10.1038/cdd.2017.145. View

19.

Diggins N, Skalsky R, Hancock M . Regulation of Latency and Reactivation by Human Cytomegalovirus miRNAs. Pathogens. 2021; 10(2). PMC: 7918750. DOI: 10.3390/pathogens10020200. View

20.

Smith W, Tomasec P, Aicheler R, Loewendorf A, Nemcovicova I, Wang E . Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses. Cell Host Microbe. 2013; 13(3):324-35. PMC: 3601332. DOI: 10.1016/j.chom.2013.02.003. View